Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Mukhopadhyay A, et al. Among authors: pantazis p. Oncogene. 2001 Nov 15;20(52):7597-609. doi: 10.1038/sj.onc.1204997. Oncogene. 2001. PMID: 11753638
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC, Kouros-Mehr H, Kohn KW, Maunakea AK, Lababidi S, Roschke A, Stover K, Alexander J, Pantazis P, Miller L, Liu E, Kirsch IR, Urasaki Y, Pommier Y, Weinstein JN. Reinhold WC, et al. Among authors: pantazis p. Cancer Res. 2003 Mar 1;63(5):1000-11. Cancer Res. 2003. PMID: 12615715
Differential susceptibility to 9-nitrocamptothecin (9-NC)-induced apoptosis in clones derived from a human ovarian cancer cell line: possible implications in the treatment of ovarian cancer patients with 9-NC.
Hu X, Balan KV, Ramos-DeSimone N, Wyche JH, Han Z, Pantazis P. Hu X, et al. Among authors: pantazis p. Anticancer Drugs. 2003 Jul;14(6):427-36. doi: 10.1097/00001813-200307000-00007. Anticancer Drugs. 2003. PMID: 12853884
Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
Chatterjee D, Goldman M, Braastad CD, Darnowski J, Wyche JH, Pantazis P, Goodglick L. Chatterjee D, et al. Among authors: pantazis p. Int J Oncol. 2004 Aug;25(2):503-9. Int J Oncol. 2004. PMID: 15254750
Cellular resistance to vincristine suppresses NF-kappa B activation and apoptosis but enhances c-Jun-NH2-terminal protein kinase activation by tumor necrosis.
Giri DK, Pantazis P, Aggarwal BB. Giri DK, et al. Among authors: pantazis p. Apoptosis. 1999 Aug;4(4):291-301. doi: 10.1023/a:1026413111733. Apoptosis. 1999. PMID: 14692400
Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines.
Mehta K, Pantazis P, McQueen T, Aggarwal BB. Mehta K, et al. Among authors: pantazis p. Anticancer Drugs. 1997 Jun;8(5):470-81. doi: 10.1097/00001813-199706000-00010. Anticancer Drugs. 1997. PMID: 9215611
Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
Pantazis P, Mendoza JT, DeJesus A, Rubin E, Kufe D, Giovanella BC. Pantazis P, et al. Eur J Haematol. 1994 Sep;53(3):135-44. doi: 10.1111/j.1600-0609.1994.tb00661.x. Eur J Haematol. 1994. PMID: 7925856
Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
Urasaki Y, Laco GS, Pourquier P, Takebayashi Y, Kohlhagen G, Gioffre C, Zhang H, Chatterjee D, Pantazis P, Pommier Y. Urasaki Y, et al. Among authors: pantazis p. Cancer Res. 2001 Mar 1;61(5):1964-9. Cancer Res. 2001. PMID: 11280753
Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro.
Pantazis P, Kozielski AJ, Mendoza JT, Early JA, Hinz HR, Giovanella BC. Pantazis P, et al. Int J Cancer. 1993 Mar 12;53(5):863-71. doi: 10.1002/ijc.2910530526. Int J Cancer. 1993. PMID: 8449612
Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
Singh S, Raju U, Mendoza J, Pantazis P, Aggarwal BB. Singh S, et al. Among authors: pantazis p. Anticancer Drugs. 1998 Sep;9(8):703-14. doi: 10.1097/00001813-199809000-00006. Anticancer Drugs. 1998. PMID: 9823429
154 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page